Kloxxado - (8 mg/spray; Nasal Spray)

Generic Name	Naloxone Hydrochloride	Innovator	Hikma
Dosage	8 mg/spray; Nasal Spray	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	KLOXXADO is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and pediatric patients.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
*******	*** / *********	*** **, ****	********* ** ****** ** *******	****	******* *** **** *** *** ****
*****	** \ **	*** *, ****	*******	****	*** ****** *** ****

Chronology Of Events